UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM SD
Specialized Disclosure Report
ATRICURE, INC.
(Exact name of registrant as specified in charter)
Delaware | 000-51470 | 34-1940305 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) | ||
6217 Centre Park Drive West Chester, OH |
45069 | |||
(Address of principal executive offices) | (Zip Code) |
M. Andrew Wade | (513) 755-4100 | |
(Name and telephone number, including area code, of the person to contact in connection with this report.) |
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
x | Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2013. |
Section 1. Conflict Minerals Disclosure
Item 1.01. Conflict Minerals Disclosure and Report
AtriCure, Inc. (AtriCure or the Company) evaluated its products during the year ended December 31, 2013 and determined that certain products manufactured or contracted to be manufactured by the Company contain tin, tungsten, tantalum, and/or gold. As a result, the Company has filed a Conflict Minerals Report (CMR). A copy of the Companys CMR is furnished as Exhibit 1.02 to this Form SD and is incorporated herein by reference. A copy of the Companys CMR is also available on the Companys website at www.atricure.com.
Item 1.02 Exhibit
A copy of the Companys Conflict Minerals Report required by Item 1.01 is provided as Exhibit 1.02 hereto.
Section 2. Exhibits
Item 2.01. Exhibits
(d) | Exhibits |
No. |
Description | |
1.02 | Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ATRICURE, INC. | ||||||
Dated: June 2, 2014 | By: | /s/ M. Andrew Wade | ||||
M. Andrew Wade | ||||||
Vice President and Chief Financial Officer |